Rwanda/Uganda – Through CDC, made four visits to assist Ministry of Health
national HIV and Tb laboratories improve facilities, operations, biosafety and
biosecurity (2010-2011)
Ghana – presented several sessions at the 2nd African
Biosafety Association (AfBSA) meetings (2011)
Nigeria – participated in an ASM-CDC sponsored biosafety
symposium as one of two instructors in this week-long program (2011)
China – presented two-day BSL-3 Workshop, Singapore (2009)
Japan – participated in Japanese BSL-3 Symposium,
Tokyo (2008)
France – presented “Protecting Employees: Exposure Risk
Assessment and Health surveillance”, ISPE Conference, Paris (2008)
China – Masterclass on International Biosafety
Facilities, sponsored by China-US Collaborative Program on emerging and
Re-Emerging Infectious Diseases, Beijing (2007)
Japan – presented “Current Situation of BSL-4 Facilities
in the World” at a Japanese International Symposium (2007)
Egypt – conducted biosafety training, “Biopyramids”,
Cairo (2006)
Brazil – conducted week-long biosafety training for
laboratorians and facilities engineers from 21 newly-established BSL-3
laboratories (2006)
Brazil – Seminário International de Biosseguranҫa em
Saúde (2005)
Former Soviet Union – 3rd Moscow International
Congress on Biotechnology : “Biosecurity – A Consequence of Uncertainty” (2005)
World Health
Organization, Biosafety Programme –Served as biosafety advisor for three months in Geneva,
Switzerland (2004)
China: Beijing -- Investigated SARS laboratory-acquired infections
at China CDC (2004)
Brazil – Invited to present at Brazilian Virology
Conference (2004)
Singapore Ministry of
Health: Design review team
for patient containment facilities for new infectious disease hospital (2003)
Brazil – Associaҫão Nacional de Biosseguranҫa, “For his
contribution to the development of Biosafety in Brazil” (2003)
Biosafety Advisory
Group, World Health Organization, member (1990-2002)
Biosafety Review of
Seven Laboratories for the Indian Council of Medical Research: Evaluated needs for BSL-3 facilities at
the National Institute of Cholera and Enteric Diseases (NICED) in Koltata,
National Institute of Communicable Diseases (NICD) in New Delhi, National
Institute of Virology (NIV) in Pune, Microbial Containment Complex/ Enterovirus
Research Center in Mumbai, Tuberculosis Research Centre in Chennai, and the
Institute for Research in Reproduction (2001)
Uganda Virus Research
Institute, Entebbe: Review lab design,
operation for BSL-3 up-grade for HIV/Tb activities (1997, 2000)
Center International de
Researches Medicales, Franceville, Gabon: Review BSL-4 laboratory operations (1999)
State Research Center of
Virology and Biotechnology (“Vector”), Koltsovo, Novosibirsk Region, Russia: Evaluation of facilities and programs to provide
necessary biosafety in research work with highly dangerous pathogens at BSL-4 (1999)
Emerging and Re-Emerging
Infectious Diseases and Disease Surveillance (ERIDDS) Activities in New Delhi,
Pune, Chennai and Calcutta, India: Evaluate laboratory needs for research conducted at
each of these Institutes for the Indian Council of Medical Research (ICMR) (1999)
HIV Laboratory, Kisumu,
Kenya: Reviewed design,
construction and certification of a tissue culture laboratory to support HIV/AIDS
research project (1998)
Maximum Containment
Commissioning Team, Lyon,
France (1998)
Tb Laboratory, Pulmonary
Diagnostic Institute, Abidjan, Côte d’Iviore: Evaluate existing facility and propose new laboratory design
(1998)
State Research Center
for Applied Microbiology (SCRAM), Obolensk, Serpukhov District, Moscow Region,
Russia: Evaluation
of laboratory and animal facilities for work with especially dangerous
pathogens (BSL-3), International Science and Technology Center (1998)
International Center for
Diarrheal Disease Research, Dhaka, Bangladesh: Biosafety review, training, containment
certification (1996, 1997)
HIV/AIDS Program,
Bangkok, Thailand: Biosafety review,
training, contaiment certification (1997)
National Institute of
Biologics, New Delhi, India: Biosafety training, new facility review (1997)
National Institute of
Infectious Diseases, Tokyo, Japan: Biosafety facility and program review, training (1997)
National Laboratories
for Human and Animal Health, Winnipeg, Canada: Biosafety facility and program review,
Tier 2 Commissioning phase (1997)
Review of Brazilian
System of National Public Health Laboratory Network: Conducted laboratory assessments of
seven institutes throughout Brazil for the Ministry of Health (1997)
Arbovirus Laboratory,
KEMRI, Nairobi, Kenya:Proposed
details for renovation of laboratory to meet BSL-3 standards (1997)
Project RETRO-CI,
Abidjan, Côte d’Ivoire, Africa: Design and certification of BSL-3 laboratories for work withM.
tuberculosis and HIV (1994-96)
Viral Diagnostic
Laboratory, Toronto, Canada:
Review and public discussion of safety matters associated with a BSL-4
laboratory (glove box line) for work with exotic human pathogens (1995)
Plasma-derived Hepatitis
B Vaccine Project, Bulandshar, Uttar Pradesh, India: Conduct biosafety evaluation of a new HBV
vaccine production facility, an Indo-U.S. vaccine action program (1994)
